Abstract
Apex Market Research has published a new report titled ”Global Autoimmune Disease Therapeutics Market share, forecast data, In-Depth Analysis, and Forecast, 2020-2027”. According to the report, The global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is projected to reach $153,320 million by 2025, registering a CAGR of 4.2% The report offers in-depth insights, revenue details, and other vital information regarding the global Autoimmune Disease Therapeutics market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.
Attractive Opportunities in the Autoimmune Disease Therapeutics market
The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
Global Autoimmune Disease Therapeutics market report offers in-depth insights, revenue details, and other vital information regarding the global Autoimmune Disease Therapeutics market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period.
It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest shareholder of Autoimmune Disease Therapeutics market.
The major players operating into Autoimmune Disease Therapeutics Market include:
Abbott Laboratories
AbbVie Inc.
Amgen Inc.
AstraZeneca plc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche AG
Johnson & Johnson
Novartis AG
Scope Of the Report
| Report Parameters |
Details of Parameter |
| Market Size |
2020-2027 |
| Based Year |
2019 |
| Forecast Period Covered |
2020-2027 |
| Units for value |
USD |
| Covered Segments |
Drug Class, Indication, Sales Channel |
| Region Covered |
North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)
|
This research report categorizes the Autoimmune Disease Therapeutics market to forecast revenues and analyze trends in each of the following submarkets:
By Drug Class
- Anti-inflammatory
- Antihyperglycemics
- NSAIDs
- Interferons
- Others
By Indication
- Rheumatic Disease
- Type 1 Diabetes
- Multiple Sclerosis
- Inflammatory Bowel Disease
- Other Indications
By Sales Channel
- Hospital Pharmacy
- Drug Store & Retail Pharmacy
- Online Store
There are 13 chapters to put on view for Autoimmune Disease Therapeutics Market:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview
Chapter 2: Market competition by Manufacturers
Chapter 3: Production by Regions
Chapter 4: Consumption by Regions
Chapter 5: Production, By Types, Revenue and Market share by Types
Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications
Chapter 7: Complete profiling and analysis of Manufacturers
Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses
Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Market Effect Factors Analysis
Chapter 12: Market Forecast
Chapter 13: Autoimmune Disease Therapeutics Research Findings and Conclusion, Appendix, methodology and data source
Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report.
Industry Chain Analysis
Raw Material and Suppliers
Equipment and Suppliers
Manufacturing Process
Manufacturing Cost Structure
Manufacturing Plants Distribution Analysis
Available Customizations
We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview
1.1 Autoimmune Disease Therapeutics Market Overview
1.1.1 Autoimmune Disease Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Autoimmune Disease Therapeutics Market Size and Analysis by Regions (2015-2019)
1.2.1 North America Autoimmune Disease Therapeutics Market Status and Outlook
1.2.2 EU Autoimmune Disease Therapeutics Market Status and Outlook
1.2.3 Japan Autoimmune Disease Therapeutics Market Status and Outlook
1.2.4 China Autoimmune Disease Therapeutics Market Status and Outlook
1.2.5 India Autoimmune Disease Therapeutics Market Status and Outlook
1.2.6 Southeast Asia Autoimmune Disease Therapeutics Market Status and Outlook
1.3 Global Autoimmune Disease Therapeutics Market Segment Drug Class
1.3.1 Introduction
1.3.1.1 Market Estimates And Forecast 2015-2027
1.3.2 Anti-inflammatory
1.3.2.1 Market Estimates And Forecast By Country, 2015-2027
1.3.3 Antihyperglycemics
1.3.3.1 Market Estimates And Forecast By Country, 2015-2027
1.3.4 NSAIDs
1.3.4.1 Market Estimates And Forecast By Country, 2015-2027
1.3.5 Interferons
1.3.5.1 Market Estimates And Forecast By Country, 2015-2027
1.3.6 Others
1.3.6.1 Market Estimates And Forecast By Country, 2015-2027
1.4 Global Autoimmune Disease Therapeutics Market Segment Indication
1.4.1 Introduction
1.4.1.1 Market Estimates And Forecast 2015-2027
1.4.2 Rheumatic Disease
1.4.2.1 Market Estimates And Forecast By Country, 2015-2027
1.4.3 Type 1 Diabetes
1.4.3.1 Market Estimates And Forecast By Country, 2015-2027
1.4.4 Multiple Sclerosis
1.4.4.1 Market Estimates And Forecast By Country, 2015-2027
1.4.5 Inflammatory Bowel Disease
1.4.5.1 Market Estimates And Forecast By Country, 2015-2027
1.4.6 Other Indications
1.4.6.1 Market Estimates And Forecast By Country, 2015-2027
1.5 Global Autoimmune Disease Therapeutics Market Segment Sales Channel
1.5.1 Introduction
1.5.1.1 Market Estimates And Forecast 2015-2027
1.5.2 Hospital Pharmacy
1.5.2.1 Market Estimates And Forecast By Country, 2015-2027
1.5.3 Drug Store & Retail Pharmacy
1.5.3.1 Market Estimates And Forecast By Country, 2015-2027
1.5.4 Online Store
1.5.4.1 Market Estimates And Forecast By Country, 2015-2027
Chapter 2 Global Autoimmune Disease Therapeutics Competition Analysis by Players
2.1 Global Autoimmune Disease Therapeutics Market Size (Million USD) by Players (2015-2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
Chapter 3 Company (Top Players) Profiles and Key Data
3.1 Abbott Laboratories
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Abbott Laboratories, Autoimmune Disease Therapeutics Revenue (Million USD) (2015-2019)
3.1.5 Recent Developments
3.2 AbbVie Inc.
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 AbbVie Inc., Autoimmune Disease Therapeutics Revenue (Million USD) (2015-2019)
3.2.5 Recent Developments
3.3 Amgen Inc.
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Amgen Inc., Autoimmune Disease Therapeutics Revenue (Million USD) (2015-2019)
3.3.5 Recent Developments
3.4 AstraZeneca plc.
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 AstraZeneca plc., Autoimmune Disease Therapeutics Revenue (Million USD) (2015-2019)
3.4.5 Recent Developments
3.5 Bristol-Myers Squibb Company
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Bristol-Myers Squibb Company, Autoimmune Disease Therapeutics Revenue (Million USD)(2015-2019)
3.5.5 Recent Developments
3.6 F. Hoffmann-La Roche AG
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 F. Hoffmann-La Roche AG, Autoimmune Disease Therapeutics Revenue (Million USD)(2015-2019)
3.6.5 Recent Developments
3.7 Johnson & Johnson
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Johnson & Johnson, Autoimmune Disease Therapeutics Revenue (Million USD)(2015-2019)
3.7.5 Recent Developments
3.8 Novartis AG
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Novartis AG, Autoimmune Disease Therapeutics Revenue (Million USD) (2015-2019)
3.8.5 Recent Developments
3.9 Player 8
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Player 8, Autoimmune Disease Therapeutics Revenue (Million USD) (2015-2019)
3.9.5 Recent Developments
3.10 Player-9
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Player-9, Autoimmune Disease Therapeutics Revenue (Million USD) (2015-2019)
3.10.5 Recent Developments
Chapter 4 Global Autoimmune Disease Therapeutics Market Size Type (2015-2019)
4.1 Global Autoimmune Disease Therapeutics Market Size by Type (2015-2019)
Chapter 5 Global Autoimmune Disease Therapeutics Market Size Application (2015-2019)
5.1 Global Autoimmune Disease Therapeutics Market Size by Application (2015-2019)
5.2 Potential Application of Autoimmune Disease Therapeutics in Future
5.3 Top Consumer / End Users of Autoimmune Disease Therapeutics
Chapter 6 North America Autoimmune Disease Therapeutics Development Status and Outlook
6.1 North America Autoimmune Disease Therapeutics Market Size (2015-2019)
6.2 North America Autoimmune Disease Therapeutics Market Size by Application (2015-2019)
Chapter 7 EU Autoimmune Disease Therapeutics Development Status and Outlook
7.1 EU Autoimmune Disease Therapeutics Market Size (2015-2019)
7.2 EU Autoimmune Disease Therapeutics Market Size by Application (2015-2019)
Chapter 8 Japan Autoimmune Disease Therapeutics Development Status and Outlook
8.1 Japan Autoimmune Disease Therapeutics Market Size (2015-2019)
8.2 Japan Autoimmune Disease Therapeutics Market Size by Application (2015-2019)
Chapter 9 China Autoimmune Disease Therapeutics Development Status and Outlook
9.1 China Autoimmune Disease Therapeutics Market Size and Forecast (2015-2019)
9.2 China Autoimmune Disease Therapeutics Market Size by Application (2015-2019)
Chapter 10 India Autoimmune Disease Therapeutics Development Status and Outlook
10.1 India Autoimmune Disease Therapeutics Market Size and Forecast (2015-2019)
10.2 India Autoimmune Disease Therapeutics Market Size by Application (2015-2019)
Chapter 11 Southeast Asia Autoimmune Disease Therapeutics Development Status and Outlook
11.1 Southeast Asia Autoimmune Disease Therapeutics Market Size and Forecast (2015-2019)
11.2 Southeast Asia Autoimmune Disease Therapeutics Market Size by Application (2015-2019)
Chapter 12 Market Forecast by Regions and Application (2020-2027)
12.1 Global Autoimmune Disease Therapeutics Market Size (Million USD) by Regions (2020-2027)
12.1. North America Autoimmune Disease Therapeutics Revenue and Growth Rate (2020-2027)
12.1.2 EU Autoimmune Disease Therapeutics Revenue and Growth Rate (2020-2027)
12.1.3 China Autoimmune Disease Therapeutics Revenue and Growth Rate (2020-2027)
12.1.4 Japan Autoimmune Disease Therapeutics Revenue and Growth Rate (2020-2027)
12.1.5 Southeast Asia Autoimmune Disease Therapeutics Revenue and Growth Rate (2020-2027)
12.1.6 India Autoimmune Disease Therapeutics Revenue and Growth Rate (2020-2027)
12.2 Global Autoimmune Disease Therapeutics Market Size by Application (2020-2027)
Chapter 13 Autoimmune Disease Therapeutics Market Dynamics
13.1 Autoimmune Disease Therapeutics Market Opportunities
13.2 Autoimmune Disease Therapeutics Challenge and Risk
13.2.1 Competition from Opponents
13.2.2 Downside Risks of Economy
13.3 Autoimmune Disease Therapeutics Market Constraints and Threat
13.3.1 Threat from Substitute
13.3.2 Government Policy
13.3.3 Technology Risks
13.4 Autoimmune Disease Therapeutics Market Driving Force
13.4.1 Growing Demand from Emerging Markets
13.4.2 Potential Application
Chapter 14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs Trend/Customer Preference
14.3 External Environmental Change
14.3.1 Economic Fluctuations
14.3.2 Other Risk Factors
Chapter 15 Research Finding /Conclusion
Chapter 16 Methodology and Data Source
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
16.4 Author List
